Home > Insider Trading > Filing (0001209191-20-045534)

Filing Details

Accession Number:: 0001209191-20-045534
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-06 17:35:38
Reporting Period:: 2020-08-04

Accepted Time:: 2020-08-06 17:35:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1490349	Medley Capital Corp	MCC	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1200438	Drawbridge Special Opportunities Fund Lp	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1205824	Ltd Fund Opportunites Special Drawbridge	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1245521	Fig Llc	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1252267	Drawbridge Special Opportunities Advisors Llc	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1380393	Fortress Investment Group Llc	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1380935	Drawbridge Special Opportunities Gp Llc	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1381035	Fortress Principal Investment Holdings Iv Llc	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1387344	Fortress Operating Entity I Lp	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1387345	Fig Corp.	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No
1792693	Db Med Investor I Llc	1345 Avenue Of The Americas, 46Th Floor New York NY 10105	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-08-04	1,000	$14.36	284,841	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-05	7,500	$14.51	277,341	No	4	S	Indirect	See footnote
Common Stock	Disposition	2020-08-06	2,000	$14.91	275,341	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

The price in Column 4 is a weighted average price. The actual sale prices ranged from $14.35 to $14.38 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Each reporting person disclaims beneficial ownership of all reported shares except to the extent of its pecuniary interest therein and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for the purposes of Section 16 or otherwise. DB Med Investor I LLC, a Delaware limited liability company ("DB Med"), directly owns shares of common stock of the Issuer. Drawbridge Special Opportunities Fund LP, a Delaware limited partnership ("DBSO"), and Drawbridge Special Opportunities Fund LTD, a Cayman Islands exempted company ("DBSO Ltd."), are the members of DB Med. Drawbridge Special Opportunities GP LLC, a Delaware limited liability company ("DBSO GP"), is the general partner of DBSO and DBSO Ltd. Fortress Principal Investment Holdings IV LLC, a Delaware limited liability company ("FPI IV"), is the managing member of DBSO GP. [Footnote continues below]
Drawbridge Special Opportunities Advisors LLC, a Delaware limited liability company ("DBSO Advisors"), is the investment manager of DBSO and DBSO Ltd. FIG LLC, a Delaware limited liability company, is the holder of all of the issued and outstanding interests of DBSO Advisors. Fortress Operating Entity I LP, a Delaware limited partnership ("FOE I"), is the holder of all of the issued and outstanding interests of FPI IV and the Class A member of FIG LLC. FIG Corp., a Delaware corporation, is the general partner of FOE I. Fortress Investment Group LLC, a Delaware limited liability company ("Fortress"), is the holder of all of the issued and outstanding shares of FIG Corp.
The price in Column 4 is a weighted average price. The actual sale prices ranged from $14.50 to $14.54 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average price. The actual sale prices ranged from $14.80 to $15.00 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.